Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Net Cash Flow (2016 - 2025)

iBio (IBIO) has disclosed Net Cash Flow for 16 consecutive years, with $567000.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 114.09% to $567000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.7 million through Dec 2025, up 591.95% year-over-year, with the annual reading at -$5.6 million for FY2025, 182.78% down from the prior year.
  • Net Cash Flow for Q4 2025 was $567000.0 at iBio, down from $19.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $19.5 million in Q3 2025, with the low at -$17.7 million in Q4 2021.
  • Average Net Cash Flow over 5 years is -$3.1 million, with a median of -$3.0 million recorded in 2023.
  • The sharpest move saw Net Cash Flow plummeted 473.89% in 2024, then skyrocketed 717.79% in 2025.
  • Over 5 years, Net Cash Flow stood at -$17.7 million in 2021, then soared by 32.48% to -$11.9 million in 2022, then skyrocketed by 94.13% to -$701000.0 in 2023, then tumbled by 473.89% to -$4.0 million in 2024, then soared by 114.09% to $567000.0 in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $567000.0, $19.5 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.